{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:40:33Z","timestamp":1783489233826,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T00:00:00Z","timestamp":1508976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T00:00:00Z","timestamp":1508976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The study explored differences in the steroidogenic pathway between obese and nonobese women with polycystic ovary syndrome (PCOS) using liquid chromatography-tandem mass spectrometry (LC-MS\/MS). 1044 women with PCOS (including 350 lean, 312 overweight and 382 obese) and 366 control women without PCOS (including 203 lean, 32 overweight and 131 obese) were enrolled. The differences in steroid hormones were amplified in lean PCOS versus lean controls compared with obese PCOS versus obese controls. Compared with obese PCOS, lean PCOS demonstrated increased dehydroepiandrosterone sulfate (<jats:italic>P<\/jats:italic>\u2009=\u20090.015), 17-hydropregnenolone (<jats:italic>P<\/jats:italic>\u2009=\u20090.003), 17-hydroprogesterone (17-OHP) (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), progesterone (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and estrone (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) levels. Enzyme activity evaluation showed that lean PCOS had increased activity of P450c17 (17-hydropregnenolone\/pregnenolone, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), P450aro (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), 3\u03b2HSD2 (progesterone\/ pregnenolone and 17-OHP\/17-hydropregnenolone, both <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and decreased activity of P450c21(11-deoxycorticorsterone\/progesterone and 11-deoxycortisol\/17-OHP, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Moreover, we found higher frequencies of CYP21A2- (encoding P450c21) c.552\u2009C\u2009&gt;\u2009G (p. D184E) in lean PCOS compared with obese PCOS patients (<jats:italic>P<\/jats:italic>\u2009=\u20090.006). In conclusion, this study demonstrated for the first time that the adrenal-specific enzyme P450c21 showed decreased activity in lean PCOS patients, and that the adrenal androgen excess may play different roles in lean and obese PCOS patients, which represents as different enzyme activity in the steroidogenic pathway.<\/jats:p>","DOI":"10.1038\/s41598-017-14534-2","type":"journal-article","created":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T13:47:47Z","timestamp":1508507267000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome"],"prefix":"10.1038","volume":"7","author":[{"given":"Yuying","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,26]]},"reference":[{"key":"14534_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","volume":"106","author":"D Lizneva","year":"2016","unstructured":"Lizneva, D. et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertility and sterility \n                           106, 6\u201315, https:\/\/doi.org\/10.1016\/j.fertnstert.2016.05.003 (2016).","journal-title":"Fertility and sterility"},{"key":"14534_CR2","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1210\/er.2012-1003","volume":"33","author":"HS Randeva","year":"2012","unstructured":"Randeva, H. S. et al. Cardiometabolic aspects of the polycystic ovary syndrome. Endocrine reviews \n                           33, 812\u2013841, https:\/\/doi.org\/10.1210\/er.2012-1003 (2012).","journal-title":"Endocrine reviews"},{"key":"14534_CR3","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz, R. et al. Polycystic ovary syndrome. Nature reviews. Disease primers \n                           2, 16057, https:\/\/doi.org\/10.1038\/nrdp.2016.57 (2016).","journal-title":"Disease primers"},{"key":"14534_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","volume":"36","author":"DA Dumesic","year":"2015","unstructured":"Dumesic, D. A. et al. Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocrine reviews \n                           36, 487\u2013525, https:\/\/doi.org\/10.1210\/er.2015-1018 (2015).","journal-title":"Endocrine reviews"},{"key":"14534_CR5","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz, R. et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. The Journal of clinical endocrinology and metabolism \n                           89, 2745\u20132749, https:\/\/doi.org\/10.1210\/jc.2003-032046 (2004).","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"14534_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s11154-007-9054-0","volume":"8","author":"BO Yildiz","year":"2007","unstructured":"Yildiz, B. O. & Azziz, R. The adrenal and polycystic ovary syndrome. Reviews in endocrine & metabolic disorders \n                           8, 331\u2013342, https:\/\/doi.org\/10.1007\/s11154-007-9054-0 (2007).","journal-title":"Reviews in endocrine & metabolic disorders"},{"key":"14534_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0300-595X(86)80021-4","volume":"15","author":"C Longcope","year":"1986","unstructured":"Longcope, C. Adrenal and gonadal androgen secretion in normal females. Clinics in endocrinology and metabolism \n                           15, 213\u2013228 (1986).","journal-title":"Clinics in endocrinology and metabolism"},{"key":"14534_CR8","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0015-0282(98)00536-6","volume":"71","author":"C Moran","year":"1999","unstructured":"Moran, C., Knochenhauer, E., Boots, L. R. & Azziz, R. Adrenal androgen excess in hyperandrogenism: relation to age and body mass. Fertility and sterility \n                           71, 671\u2013674 (1999).","journal-title":"Fertility and sterility"},{"key":"14534_CR9","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1365-2265.2005.02256.x","volume":"62","author":"A Kumar","year":"2005","unstructured":"Kumar, A., Woods, K. S., Bartolucci, A. A. & Azziz, R. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clinical endocrinology \n                           62, 644\u2013649, https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02256.x (2005).","journal-title":"Clinical endocrinology"},{"key":"14534_CR10","doi-asserted-by":"publisher","unstructured":"Moran, C., Arriaga, M., Arechavaleta-Velasco, F. & Moran, S. Adrenal androgen excess and body mass index in polycystic ovary syndrome. The Journal of clinical endocrinology and metabolism, jc00009999, https:\/\/doi.org\/10.1210\/jc.0000-9999 (2015).","DOI":"10.1210\/jc.0000-9999"},{"key":"14534_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1210\/jc.2006-1864","volume":"92","author":"W Rosner","year":"2007","unstructured":"Rosner, W., Auchus, R. J., Azziz, R., Sluss, P. M. & Raff, H. Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. The Journal of clinical endocrinology and metabolism \n                           92, 405\u2013413, https:\/\/doi.org\/10.1210\/jc.2006-1864 (2007).","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"14534_CR12","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz, R. et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. The Journal of clinical endocrinology and metabolism \n                           91, 4237\u20134245, https:\/\/doi.org\/10.1210\/jc.2006-0178 (2006).","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"14534_CR13","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1210\/jc.2006-1121","volume":"91","author":"ME Wierman","year":"2006","unstructured":"Wierman, M. E. et al. Androgen therapy in women: an Endocrine Society Clinical Practice guideline. The Journal of clinical endocrinology and metabolism \n                           91, 3697\u20133710, https:\/\/doi.org\/10.1210\/jc.2006-1121 (2006).","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"14534_CR14","doi-asserted-by":"publisher","first-page":"e93805","DOI":"10.1371\/journal.pone.0093805","volume":"9","author":"CC Keefe","year":"2014","unstructured":"Keefe, C. C. et al. Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry. PloS one \n                           9, e93805, https:\/\/doi.org\/10.1371\/journal.pone.0093805 (2014).","journal-title":"PloS one"},{"key":"14534_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jsbmb.2016.02.010","volume":"158","author":"K Saito","year":"2016","unstructured":"Saito, K. et al. Steroidogenic pathways involved in androgen biosynthesis in eumenorrheic women and patients with polycystic ovary syndrome. The Journal of steroid biochemistry and molecular biology \n                           158, 31\u201337, https:\/\/doi.org\/10.1016\/j.jsbmb.2016.02.010 (2016).","journal-title":"The Journal of steroid biochemistry and molecular biology"},{"key":"14534_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1365-2265.1990.tb00857.x","volume":"32","author":"DS Kiddy","year":"1990","unstructured":"Kiddy, D. S. et al. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clinical endocrinology \n                           32, 213\u2013220 (1990).","journal-title":"Clinical endocrinology"},{"key":"14534_CR17","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/j.fertnstert.2007.09.016","volume":"90","author":"C Moran","year":"2008","unstructured":"Moran, C. et al. Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome. Fertility and sterility \n                           90, 2310\u20132317, https:\/\/doi.org\/10.1016\/j.fertnstert.2007.09.016 (2008).","journal-title":"Fertility and sterility"},{"key":"14534_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejogrb.2012.09.025","volume":"166","author":"E Yasmin","year":"2013","unstructured":"Yasmin, E., Balen, A. H. & Barth, J. H. The association of body mass index and biochemical hyperandrogenaemia in women with and without polycystic ovary syndrome. European journal of obstetrics, gynecology, and reproductive biology \n                           166, 173\u2013177, https:\/\/doi.org\/10.1016\/j.ejogrb.2012.09.025 (2013).","journal-title":"European journal of obstetrics, gynecology, and reproductive biology"},{"key":"14534_CR19","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/humrep\/dew328","volume":"32","author":"DJ Handelsman","year":"2017","unstructured":"Handelsman, D. J., Teede, H. J., Desai, R., Norman, R. J. & Moran, L. J. Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome. Human reproduction (Oxford, England) \n                           32, 418\u2013422, https:\/\/doi.org\/10.1093\/humrep\/dew328 (2017).","journal-title":"Human reproduction (Oxford, England)"},{"key":"14534_CR20","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1210\/jc.2002-020557","volume":"88","author":"V Jayagopal","year":"2003","unstructured":"Jayagopal, V., Kilpatrick, E. S., Jennings, P. E., Hepburn, D. A. & Atkin, S. L. The biological variation of testosterone and sex hormone-binding globulin (SHBG) in polycystic ovarian syndrome: implications for SHBG as a surrogate marker of insulin resistance. The Journal of clinical endocrinology and metabolism \n                           88, 1528\u20131533, https:\/\/doi.org\/10.1210\/jc.2002-020557 (2003).","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"14534_CR21","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1210\/jc.2015-4009","volume":"101","author":"R Pasquali","year":"2016","unstructured":"Pasquali, R. et al. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective. The Journal of clinical endocrinology and metabolism \n                           101, 2013\u20132022, https:\/\/doi.org\/10.1210\/jc.2015-4009 (2016).","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"14534_CR22","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","volume":"84","author":"A Vermeulen","year":"1999","unstructured":"Vermeulen, A., Verdonck, L. & Kaufman, J. M. A critical evaluation of simple methods for the estimation of free testosterone in serum. The Journal of clinical endocrinology and metabolism \n                           84, 3666\u20133672, https:\/\/doi.org\/10.1210\/jcem.84.10.6079 (1999).","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"14534_CR23","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s40618-015-0403-7","volume":"39","author":"H Li","year":"2016","unstructured":"Li, H. et al. Free androgen index and Irisin in polycystic ovary syndrome. Journal of endocrinological investigation \n                           39, 549\u2013556, https:\/\/doi.org\/10.1007\/s40618-015-0403-7 (2016).","journal-title":"Journal of endocrinological investigation"},{"key":"14534_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05717-y","volume":"7","author":"M Al-Jefout","year":"2017","unstructured":"Al-Jefout, M., Alnawaiseh, N. & Al-Qtaitat, A. Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes. Scientific reports \n                           7, 5339, https:\/\/doi.org\/10.1038\/s41598-017-05717-y (2017).","journal-title":"Scientific reports"},{"key":"14534_CR25","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.fertnstert.2009.06.025","volume":"94","author":"M Pall","year":"2010","unstructured":"Pall, M., Azziz, R., Beires, J. & Pignatelli, D. The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia. Fertility and sterility \n                           94, 684\u2013689, https:\/\/doi.org\/10.1016\/j.fertnstert.2009.06.025 (2010).","journal-title":"Fertility and sterility"},{"key":"14534_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1055\/s-2003-43307","volume":"21","author":"C Moran","year":"2003","unstructured":"Moran, C. & Azziz, R. 21-hydroxylase-deficient nonclassic adrenal hyperplasia: the great pretender. Seminars in reproductive medicine \n                           21, 295\u2013300, https:\/\/doi.org\/10.1055\/s-2003-43307 (2003).","journal-title":"Seminars in reproductive medicine"},{"key":"14534_CR27","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.4158\/EP15748.DSC","volume":"21","author":"NF Goodman","year":"2015","unstructured":"Goodman, N. F. et al. American Association Of Clinical Endocrinologists, American College Of Endocrinology, And Androgen Excess And Pcos Society Disease State Clinical Review: Guide To The Best Practices In The Evaluation And Treatment Of Polycystic Ovary Syndrome\u2013Part 1. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists \n                           21, 1291\u20131300, https:\/\/doi.org\/10.4158\/ep15748.dsc (2015).","journal-title":"Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists"},{"key":"14534_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1210\/er.2010-0013","volume":"32","author":"WL Miller","year":"2011","unstructured":"Miller, W. L. & Auchus, R. J. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocrine reviews \n                           32, 81\u2013151, https:\/\/doi.org\/10.1210\/er.2010-0013 (2011).","journal-title":"Endocrine reviews"},{"key":"14534_CR29","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1056\/NEJMra021561","volume":"349","author":"PW Speiser","year":"2003","unstructured":"Speiser, P. W. & White, P. C. Congenital adrenal hyperplasia. The New England journal of medicine \n                           349, 776\u2013788, https:\/\/doi.org\/10.1056\/NEJMra021561 (2003).","journal-title":"The New England journal of medicine"},{"key":"14534_CR30","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","volume":"98","author":"RS Legro","year":"2013","unstructured":"Legro, R. S. et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. The Journal of clinical endocrinology and metabolism \n                           98, 4565\u20134592, https:\/\/doi.org\/10.1210\/jc.2013-2350 (2013).","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"14534_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1210\/jcem.85.1.6293","volume":"85","author":"P Moghetti","year":"2000","unstructured":"Moghetti, P. et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. The Journal of clinical endocrinology and metabolism \n                           85, 139\u2013146, https:\/\/doi.org\/10.1210\/jcem.85.1.6293 (2000).","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"14534_CR32","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1210\/jcem.85.8.6738","volume":"85","author":"R Pasquali","year":"2000","unstructured":"Pasquali, R. et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. The Journal of clinical endocrinology and metabolism \n                           85, 2767\u20132774, https:\/\/doi.org\/10.1210\/jcem.85.8.6738 (2000).","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"14534_CR33","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/S0140-6736(03)13493-9","volume":"361","author":"L Harborne","year":"2003","unstructured":"Harborne, L., Fleming, R., Lyall, H., Norman, J. & Sattar, N. Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. Lancet (London, England) \n                           361, 1894\u20131901, https:\/\/doi.org\/10.1016\/s0140-6736(03)13493-9 (2003).","journal-title":"Lancet (London, England)"},{"key":"14534_CR34","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ajog.2008.09.010","volume":"199","author":"R Mathur","year":"2008","unstructured":"Mathur, R., Alexander, C. J., Yano, J., Trivax, B. & Azziz, R. Use of metformin in polycystic ovary syndrome. American journal of obstetrics and gynecology \n                           199, 596\u2013609, https:\/\/doi.org\/10.1016\/j.ajog.2008.09.010 (2008).","journal-title":"American journal of obstetrics and gynecology"},{"key":"14534_CR35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1530\/eje.0.1400056","volume":"140","author":"K Unluhizarci","year":"1999","unstructured":"Unluhizarci, K., Kelestimur, F., Sahin, Y. & Bayram, F. The treatment of insulin resistance does not improve adrenal cytochrome P450c17alpha enzyme dysregulation in polycystic ovary syndrome. European journal of endocrinology\/European Federation of Endocrine Societies \n                           140, 56\u201361 (1999).","journal-title":"European journal of endocrinology\/European Federation of Endocrine Societies"},{"key":"14534_CR36","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/humrep\/deh103","volume":"19","author":"E Vanky","year":"2004","unstructured":"Vanky, E., Salvesen, K. A. & Carlsen, S. M. Six-month treatment with low-dose dexamethasone further reduces androgen levels in PCOS women treated with diet and lifestyle advice, and metformin. Human reproduction (Oxford, England) \n                           19, 529\u2013533, https:\/\/doi.org\/10.1093\/humrep\/deh103 (2004).","journal-title":"Human reproduction (Oxford, England)"},{"key":"14534_CR37","doi-asserted-by":"crossref","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human reproduction (Oxford, England) \n                           19, 41\u201347 (2004).","DOI":"10.1093\/humrep\/deh098"},{"key":"14534_CR38","unstructured":"Health, N. I. o. Evidence-based methodology workshop on polycystic ovary syndrome, December 3\u20135, 2012.Executive summary. Available at: https:\/\/prevention.nih.gov\/docs\/programs\/pcos\/FinalReport.pdf. Accessed March 1, 2016)."},{"key":"14534_CR39","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.fertnstert.2016.12.029","volume":"107","author":"P Liang","year":"2017","unstructured":"Liang, P. et al. Prevalence of polycystic ovary syndrome in Chinese obese women of reproductive age with or without metabolic syndrome. Fertility and sterility \n                           107, 1048\u20131054, https:\/\/doi.org\/10.1016\/j.fertnstert.2016.12.029 (2017).","journal-title":"Fertility and sterility"},{"key":"14534_CR40","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.fertnstert.2009.12.081","volume":"94","author":"T Naessen","year":"2010","unstructured":"Naessen, T. et al. Steroid profiles in ovarian follicular fluid in women with and without polycystic ovary syndrome, analyzed by liquid chromatography-tandem mass spectrometry. Fertility and sterility \n                           94, 2228\u20132233, https:\/\/doi.org\/10.1016\/j.fertnstert.2009.12.081 (2010).","journal-title":"Fertility and sterility"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14534-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14534-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14534-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T12:44:53Z","timestamp":1671799493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-14534-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,26]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["14534"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-14534-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,26]]},"assertion":[{"value":"18 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14156"}}